Endpoints and Management in Inflammatory Bowel Disease


Dr. David T. Rubin, Joseph B. Kirsner Professor of Medicine, discusses the preferred outcomes of IBD management and issues with current treatment strategies.  Dr. Rubin also explains the benefits and limitations of therapy approaches and describes the potential future methodologies for drug selection and dosing.  



David T. Rubin

David T. Rubin, MD

Co-Director, Digestive Diseases Center

Admissions, Referrals and Consultations:

Call UCM Physician Connect at
Contact Us

Sign Up for Email Newsletters

Learn more >